Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-05-01T01:02:33.348Z Has data issue: false hasContentIssue false

12 - Medullary thyroid carcinoma

Published online by Cambridge University Press:  05 September 2014

Grace C. H. Yang
Affiliation:
Weill Medical College of Cornell University
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Matias-Guiu, X, DeLellis, RA, Moley, JF, et al. Medullary thyroid carcinoma. In: DeLellis, RA, Lloyd, RV, Heitz, PU, Eng, C (eds.) Pathology and Genetics of Tumours of Endocrine Organs. World Health Organization Classification of Tumours. Lyons: IARC Press, 2004: 86–91.Google Scholar
Mulligan, LM, Kwok, JBJ, Healey, CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458–60.CrossRefGoogle ScholarPubMed
Hofstra, RMW, Landsvater, RM, Ceccherini, I, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994; 367: 375–6.CrossRefGoogle ScholarPubMed
Santoro, M, Rosati, R, Grieco, M, et al. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 1990; 5: 1595–8.Google ScholarPubMed
Goodfellow, PJ.Mapping the inherited defects associated with multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma to chromosome 10 by linkage analysis. Endocrinol Metab Clin North Am 1994; 23: 177–85.Google ScholarPubMed
Schimke, RN, Hartmann, WH.Familial amyloid-producing medullary thyroid carcinoma and pheochromocytoma: A distinct genetic entity. Ann Intern Med 1965; 63: 1027–37.CrossRefGoogle ScholarPubMed
Brandi, ML, Gagel, RF, Angeli, A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86: 5658–71.CrossRefGoogle ScholarPubMed
Marsh, DJ, Robinson, BG, Andrew, S, et al. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. Genomics 1994; 23: 477–9.CrossRefGoogle ScholarPubMed
Ries, LAG, Melbert, D, Krapcho, M, et al. Surveillance, Epidemiology, and End (SEER) Program: Cancer Statistics Review, 1975–2004. Bethesda, MD: National Cancer Institute, 2007. ()Google Scholar
Jimenez, C, Hu, MI, Gagel, RF.Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am 2008; 37: 481–4, x–xi.CrossRefGoogle ScholarPubMed
Reubi, JC, Chayvialle, JA, Franc, B, et al. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest 1991; 64: 567–73.Google ScholarPubMed
Lamberts, SWJ, Bakker, WH, Reubi, JC, et al. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990; 323: 1246–9.CrossRefGoogle ScholarPubMed
Lamberts, SWJ, Krenning, EP, Reubi, JC.The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991; 12: 450–82.CrossRefGoogle ScholarPubMed
Biddinger, PW, Ray, M.Distribution of C cells in the normal and diseased thyroid gland. Pathol Annu 1993; 28: 205–29.Google ScholarPubMed
Yang, GCH, Nieto, R, Stachura, I, Gallo, GR.Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the Congo red-negative amyloid-like fibrils of fibrillary glomerulopathy. Am J Pathol 1992; 141: 409–20.Google ScholarPubMed
Papaparaskeva, K, Nagel, H, Droese, M.Cytologic diagnosis of medullary carcinoma of the thyroid gland. Diagn Cytopathol 2000; 22: 351–8.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Schreiner, AM, Yang, GCH.Medullary thyroid carcinoma presenting as rectangular cell type on fine needle aspiration: A diagnostic dilemma. Diagn Cytopathol 2009; 37: 213–16.CrossRefGoogle Scholar
Chang, TC, Wu, SL, Hsiao, YL.Medullary thyroid carcinoma: Pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET Proto-oncogene mutations. Acta Cytol 2005; 49: 477–82.CrossRefGoogle ScholarPubMed
Kazaure, HS, Roman, SA, Sosa, JA.Medullary thyroid microcarcinoma: A population-level analysis of 310 patients. Cancer 2012; 118: 620–7.CrossRefGoogle ScholarPubMed
Etit, D, Faquin, WC, Gaz, R, et al. Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: A study of 42 cases. Arch Pathol Lab Med 2008; 132: 1767–73.Google ScholarPubMed
Yang, GCH, Fried, K, Levine, PH. Detection of medullary thyroid microcarcinoma using ultrasound-guided fine-needle aspiration cytology. Cytopathology [Epub 2012 Mar 20].
Giorgadze, TA, Baloch, ZW, Pasha, T, Zhang, PJ, Livolsi, VA.Lymphatic and blood vessel density in the follicular patterned lesions of thyroid. Mod Pathol 2005; 18: 1424–31.CrossRefGoogle ScholarPubMed
Heilo, A, Sigstad, E, Grøholt, K.Atlas of Thyroid Lesions. New York: Springer, 2011.CrossRefGoogle Scholar
Yang, GCH, Liebeskind, D, Messina, AV.Should cytopathologists stop reporting follicular neoplasms in fine needle aspiration of the thyroid? Diagnosis and histologic follow-up of 147 cases. Cancer (Cancer Cytopathol) 2003; 99: 69–74.CrossRefGoogle Scholar
Bose, S, Kapila, K, Verma, K.Medullary carcinoma of the thyroid: a cytological, immunocytochemical, and ultrastructural study. Diagn Cytopathol 1992; 8: 28–32.CrossRefGoogle ScholarPubMed
Takami, H, Bessho, T, Kameya, T, et al. Immunohistochemical study of medullary thyroid carcinoma: Relationship of clinical features to prognostic factors in 36 patients. World J Surg 1988; 12: 572–9.CrossRefGoogle ScholarPubMed
Green, I, Ali, SZ, Allen, EA, Zakowski, MF.A spectrum of cytomorphologic variations in medullary thyroid carcinoma: Fine-needle aspiration findings in 19 cases. Cancer (Cancer Cytopathol) 1997; 81: 40–4.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Chernyavsky, VS, Farghani, S, Davidov, T, et al. Calcitonin-negative neuroendocrine tumor of the thyroid: A distinct clinical entity. Thyroid 2011; 21: 193–6.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×